Following the publication of the Review by Sang Kyun Sohn and Joon Ho Moon, ‘When is the optimal timing for allogeneic transplantation in the case of MDS patients treated with hypomethylating agents?’ published in the August 2013 issue of Expert Review of Hematology (Expert Rev. Hematol. 6[4], 389–395 [2013]), it has been brought to our attention that the following inaccuracies appeared:
The financial & competing interests disclosure appeared as:
“The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.”
It should have appeared as the following:
“This study was supported by KNU academic fund. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.”
The authors and editors of Expert Review of Hematology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.